Abstract topics

Welcome to EULAR 2024

WELCOME |   REGULAR SUBMISSION | LATE BREAKING SUBMISSION | CLINICAL CASE REPORT | TOPICS | ABSTRACT EMBARGO


Abstract SUBMISSION topics & KEYWORDS

Tracks A and B are subdivided into 27 abstract topics by disease:

  1. Antiphospholipid syndrome
  2. Autoinflammatory diseases, Vexas and other monogenic diseases
  3. Behcet's disease
  4. COVID-19
  5. Crystal related disorders
  6. Pain in rheumatic diseases, including fibromyalgia
  7. Immunodeficiency
  8. Infection-related rheumatic diseases
  9. Inflammatory arthritis
  10. Inflammatory myopathies
  11. Juvenile idiopathic arthritis
  12. Metabolic bone diseases and osteoporosis
  13. Mixed connective tissue disease
  14. Osteoarthritis and other mechanical musculoskeletal problems
  15. Other connective tissue diseases
  16. Psoriatic arthritis
  17. Rheumatoid arthritis
  18. Sarcoidosis
  19. Sjá½…gren's syndrome
  20. Spondyloarthritis
  21. Systemic lupus erythematosus
  22. Systemic sclerosis
  23. Vasculitis, small and medium size vessels
  24. Vasculitis, large vessels including polymyalgia rheumatica
  25. Public health
  26. Other diseases
  27. Across diseases

 

HPR Track (C) is subdivided into the following categories:

28. HPR Measuring health
29. HPR Epidemiology and public health
30. HPR Interventions
31. HPR Patients' perspectives
32. HPR Implementation and service evaluation
33. HPR Professional education, training and competencies

 

PARE Track (D) is subdivided into the following categories:

34. Patient information and education
35. Building patient led organisations
36. Arthritis research
37. Innovations in arthritis health care
38. Psychosocial support
39. Work and rehabilitation
40. Best practice campaigning

PAED Track (E) covers all diseases (no subcategories). 

Keywords are words or phrases that are relevant to the content of your abstract and specifically define your research work:

  • Adaptive immunity
  • Analgesics
  • Animal Models
  • Anti-Inflammatory Agents, Non-Steroidal
  • Artificial Intelligence
  • Atherosclerosis
  • Autoantibodies
  • Best practices
  • biological DMARD
  • Biomarkers
  • Biosimilar Pharmaceuticals
  • Bone
  • Campaigning
  • Cardiovascular diseases
  • Cartilage
  • Clinical Trial
  • Cognitive Function
  • Comorbidities
  • Cytokines and Chemokines
  • Descriptive Studies
  • Diagnostic test
  • Diet and Nutrition
  • Digital health/Measuring health
  • Disease-modifying Drugs (DMARDs)
  • Economics
  • Education
  • Enthesitis
  • Epidemiology
  • Epigenetics
  • Ethics
  • Fibroblasts
  • Gastrointestinal tract
  • Genetics
  • Geographical differences
  • Glucocorticoids
  • Health services research
  • Heart
  • Imaging
  • Innate immunity
  • Interdisciplinary research
  • Investor initiated trial
  • Kidneys
  • Lifestyles
  • Lungs
  • Magnetic Resonance Imaging
  • Malignancy
  • Mental health
  • Microbiome
  • Motor function
  • Non-pharmacological interventions
  • Nursing
  • Observational studies / registry
  • Occupational therapy
  • -omics
  • Outcome measures
  • Pain
  • Patient information and education
  • Patient organizations
  • Patient Reported Outcome Measures
  • Patient-led research
  • Physical therapy/Physiotherapy
  • Pregnancy and reproduction
  • Prognostic factors
  • Psychology
  • Public health
  • Qualitative research
  • Quality of care
  • Quality of life
  • Randomized controlled trial
  • Rare/orphan diseases
  • Real-world evidence
  • Registries
  • Rehabilitation
  • Remission
  • Safety
  • Sarcopenia
  • Self-management
  • Sex/gender/diversity
  • Skin
  • Social work
  • Synovium
  • Systematic review
  • Tapering
  • Targeted synthetic drugs
  • Telemedicine
  • Ultrasound
  • Uveitis
  • Vaccination/Immunization
  • Validation
  • Vitamin D
  • Work-related issues

 

EULAR 2024  | CONGRESS
12 –15 JUNE

Regular Abstract and Case Report Submission 

Opens 1 October 2023

Deadline 15 January 2024

 

Online publication (full text body and list of authors) Approx two weeks prior to the congress.
 

Grant for publishing licence

 

Late-Breaking Abstract submission 

Opens 15 April 2024

Deadline 28 April 2024

Guidelines available here

 

Travel Bursary 
Opens
1 October 2023

Deadline 31 January 2024*
 

*Upon regular abstract submission (case report excluded), presenting authors may apply for travel bursary. Only presenting authors are entitled to apply for a travel bursary. Read more.


Registration for onsite tickets

Opens 01 November 2023

 

Read more

 

Online abstract publication 2023

Abstracts for EULAR 2023 are available via the Abstract Archive.

 

ARD supplement - EULAR 2023 Abstract book
2023 Eular Congress Abstract Book

 


FAQs

Find the answers to frequently asked questions around the EULAR Congress event.

 

Access the Abstract FAQs*

 


*Deadlines apply at 23:59 CET/CEST